<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04109326</url>
  </required_header>
  <id_info>
    <org_study_id>VA2012/39</org_study_id>
    <secondary_id>2012-A01648-35</secondary_id>
    <nct_id>NCT04109326</nct_id>
  </id_info>
  <brief_title>Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer Patients</brief_title>
  <acronym>APAD2</acronym>
  <official_title>Effect of a Tailored Program of Physical Activity and Nutritional Therapeutic Education on Clinical, Psychological and Sociological Factors in Breast Cancer Patients Undergoing Adjuvant Treatment : Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut du Cancer de Montpellier - Val d'Aurelle</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut du Cancer de Montpellier - Val d'Aurelle</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter randomized controlled trial aims to evaluate the effect of a tailored
      program of physical activity and nutritional therapeutic education on clinical, psychological
      and sociological factors in breast cancer patients undergoing adjuvant treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The experimental arm &quot;APAD&quot;: tailored PA program associated with individual nutritional
      counseling whilst hospitalization and at home during the 26-week duration of adjuvant
      treatment

      The experimental program will include:

        -  8 PA sessions supervised at the hospital centers and 44 unsupervised home sessions, to
           be performed twice a week.

        -  6 consultations for nutrition education to teach the principles of well balanced diet,
           to foster weigh control during treatment, and to induce appropriate feeding behaviors
           after treatment.

      The control arm: standard of care
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2013</start_date>
  <completion_date type="Actual">June 11, 2016</completion_date>
  <primary_completion_date type="Actual">January 5, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The experimental arm &quot;APAD&quot;: tailored PA program associated with individual nutritional counseling whilst hospitalization and at home during the 26-week duration of adjuvant treatment
The control arm: standard of care</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of cancer-related fatigue</measure>
    <time_frame>6 months</time_frame>
    <description>The primary assessment criterion is subjective fatigue measured using the 'General Fatigue' subscale of the Multidimensional Fatigue Inventory (MFI-20) questionnaire.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Adapted Physical Activity and Dietetique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tailored PA program associated with individual nutritional counseling whilst hospitalization and at home during the 26-week duration of adjuvant treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>APAD</intervention_name>
    <description>8 PA sessions supervised at the hospital centers and 44 unsupervised home sessions, to be performed twice a week.
6 consultations for nutrition education to teach the principles of well balanced diet, to foster weigh control during treatment, and to induce appropriate feeding behaviors after treatment.</description>
    <arm_group_label>Adapted Physical Activity and Dietetique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patient with histologically proven breast cancer

          -  Age ≥18 years old

          -  Patients having undergone curative surgery and eligible to 6 cycles of adjuvant
             chemotherapy (6 FEC100, or 3FEC100 + 3 taxanes) followed by radiotherapy

          -  Satisfactory healing from surgical act on breast and lymph nodes

          -  Ability to understand the nature, goal and study methodology

          -  Consent to cooperate for clinical assessments

          -  Affiliation to a social security regime or beneficiary of equivalent social protection

          -  Written informed consent provided before any study specific procedures

        Exclusion Criteria:

          -  Metastatic disease

          -  Any other primary tumor

          -  Contra-indication to moderate physical activity: Unchecked high blood pressure; family
             history of sudden death in a first degree relative; not stabilized heart disease;
             acute or chronic lung disease resulting in dyspnea for moderate effort; uncontrolled
             diabetes, carrying a stent; other severe pathologies unstabilized, disabled or not
             indicated to physical practice.

          -  Contra-indication to adjuvant chemotherapy or radiotherapy

          -  Pregnancy or breast feeding (according to the recommendations of the usual adjuvant
             breast cancer)

          -  Inability to attend or comply with interventions or follow-up scheduling, disability
             or difficulty preventing a proper understanding of trial instructions

          -  Legal inability or restricted legal ability
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles Romieu</last_name>
    <role>Study Chair</role>
    <affiliation>Institut du Cancer de Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Sainte Catherine</name>
      <address>
        <city>Avignon</city>
        <zip>84918</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Ambroise Paré</name>
      <address>
        <city>Marseille</city>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICM</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Montélimar</name>
      <address>
        <city>Montélimar</city>
        <zip>26216</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Cancéologie de l'Ouest</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 27, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>September 27, 2019</last_update_submitted>
  <last_update_submitted_qc>September 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Physical activity</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Therapeutic education</keyword>
  <keyword>Breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

